sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group's Stake Disclosure in Mural Oncology
The Vanguard Group, Inc. has disclosed its position regarding Mural Oncology plc in a regulatory filing dated June 17, 2025. According to Form 8.3 submitted to the Irish Takeover Panel, The Vanguard Group holds 773,091 ordinary shares of Mural Oncology, representing a 4.48% interest in the company.
Classified as $0.01 ordinary shares, The Vanguard Group engaged in recent securities transactions, purchasing 48 shares and selling 16, each at a price of 2.44 USD. No cash-settled or stock-settled derivatives or related agreements were reported. Additionally, there are no indemnity or option arrangements, nor are there any voting agreements or plans for future security acquisitions or disposals.
This disclosure is part of the requirements under the Irish Takeover Panel Act of 1997 and the 2022 Takeover Rules, aimed at maintaining transparency concerning significant interests in relevant securities.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.